Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Dutasteride injections can help treat hair loss in men and women.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Ocrelizumab may cause pancreatitis in some patients.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

DPCP can help regrow hair in some people with severe alopecia.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

To improve use of the contraceptive DMPA among adolescents, effectively manage side effects like menstrual changes and weight gain through counseling and guidance.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Intralesional vitamin D3 is an effective and safe treatment for patchy alopecia areata with fewer side effects.

Secukinumab for psoriasis may cause hair loss.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Ustekinumab helped three kids with alopecia areata regrow hair.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.